Estech has announced that the first three patients with persistent and long-standing persistent atrial fibrillation (AF) have been enrolled in the HISTORIC-AF European multicentre staged hybrid ablation clinical study.
The study is a two-step procedure, the first stage is a minimally invasive endoscopic epicardial ablation utilising the Cobra Adhere device to separate the posterior left atrium.
Go deeper with GlobalData
Four to six weeks later, the second stage is performed using electrophysiological mapping and endocardial catheter ablation.
Civil Hospital of the University of Brescia Medical School, Italy, electrophysiologist Antonio Curnis said the staged approach provides superior clinical success with efficient workflow.
”This will allow us to treat a large population of AF patients previously thought unsuitable for catheter or surgical ablation alone," he added.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
